{"mainPropery":{"diseaseId":7339,"diseaseName":"Pars planitis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7339/pars-planitis","synonyms":["Familial pars planitis (subtype)","Intermediate uveitis","Peripheral retinal inflammation","Vitritis"],"synonyms-with-source":[{"name":"Familial pars planitis (subtype)"},{"name":"Intermediate uveitis"},{"name":"Peripheral retinal inflammation"},{"name":"Vitritis"}],"identifiers":[{"identifierType":"OMIM","identifierId":"606177"},{"identifierType":"UMLS","identifierId":"C0030593"}]},"diseaseCategories":[],"organizations":[{"resourceID":487,"resourceName":"American Uveitis Society","abbreviation":"","address1":"Office of the Executive Secretary","address2":"700 18th Street South Suite 601","address3":"","address4":"","address5":"","city":"Birmingham","state":"AL","zip":"35233","country":"United States","phone":"+1-205-325-8507","tty":"","tollFree":"","fax":"","email":"","url":"https://uveitissociety.org/","freeText":""},{"resourceID":757,"resourceName":"Ocular Immunology and Uveitis Foundation","abbreviation":"","address1":"348 Glen Road","address2":"","address3":"","address4":"","address5":"","city":"Weston","state":"MA","zip":"02493","country":"United States","phone":"+1-781-647-1431","tty":"","tollFree":"","fax":"","email":"fosters@uveitis.org; ajustus@mersi.com (support)","url":"https://uveitis.org/","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/606177' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Pars%20planitis%5BTitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Pars planitis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Pars+planitis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Pars planitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":509,"resourceId":1281,"resourceName":"Pars Planitis - Resources","descriptionText":"<a href='http://www.geteyesmart.org/eyesmart/diseases/uveitis.cfm ' target='_blank'>The American Academy of Ophthalmology</a> provides information about pars planitis. Click on the link to view the information related to this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/467/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001005.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1208794-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1564,"resourceId":2180,"resourceName":"National Eye Institute","descriptionText":"The <a href='http://www.nei.nih.gov/' target='_blank'>National Eye Institute</a> (NEI) provides more information on this topic. You can reach them by calling 301-496-5248 or by E-mail at 2020@nei.nih.gov","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:606177' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/uveitis' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":4636,"questionText":"What is pars planitis?","answerText":"<strong>Pars planitis </strong>is a disease of the eye that is characterized by inflammation of the narrowed area (pars plana) between the colored part of the eye (iris) and the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002318.htm\" target=\"_blank\">choroid</a>. This may lead to blurred vision; dark, floating spots in the vision; and progressive vision loss. As the condition advances, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001001.htm\" target=\"_blank\">cataracts</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001027.htm\" target=\"_blank\">retinal detachment</a>, or macular edema (fluid within the retina) may develop. Pars planitis most often affects young men and is generally not associated with any other disease or symptoms (idiopathic); however, it can be associated with other <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">autoimmune conditions</a> such as <a href=\"https://rarediseases.info.nih.gov/gard/10255/multiple-sclerosis/resources/1\" target=\"_blank\">multiple sclerosis</a> and <a href=\"https://rarediseases.info.nih.gov/gard/7607/sarcoidosis/resources/1\" target=\"_blank\">sarcoidosis</a>. Treatment typically includes <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroid</a> drugs, immunosuppressive medications, and/or surgery.[9139][9140][9141]","dateModified":"2015-06-23T00:00:00"},"basicQuestions":[{"questionId":8985,"questionText":"What are the signs and symptoms of pars planitis?","answerText":"Pars planitis is characterized by inflammation of the narrowed area (pars plana) between the colored part of the eye (iris) and the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002318.htm\" target=\"_blank\">choroid</a>. This may lead to blurred vision; dark, floating spots in the vision; and progressive vision loss.[9139][9140] Approximately 80% of cases are bilateral (affecting both eyes), although one eye is typically more affected than the other. As the condition advances, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001001.htm\" target=\"_blank\">cataracts</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001027.htm\" target=\"_blank\">retinal detachment</a>, or macular edema (fluid within the retina) may develop.[9141]","dateModified":"2015-06-22T20:51:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9139,"authors":"","articleTitle":"Pars Planitis","bookWebsiteJournalTitle":"NORD","date":"2008","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/pars-planitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9140,"authors":"Robert H Janigian, Jr, MD","articleTitle":"Intermediate Uveitis","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1208794-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9141,"authors":"Michael Tolentino, MD; Reza Dana, MD, MPH, MSc","articleTitle":"Retinal vasculitis associated with primary ocular disorders","bookWebsiteJournalTitle":"UpToDate","date":"November 2014","volume":"","pages":"","url":"","dateAccessed":"2015-06-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8986,"questionText":"What causes pars planitis?","answerText":"The exact underlying cause of pars planitis is unknown. Scientists suspect that it is an <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">autoimmune condition</a> in which the body's <a href=\"http://www.nlm.nih.gov/medlineplus/immunesystemanddisorders.html\" target=\"_blank\">immune system</a> mistakenly attacks healthy tissues (certain parts of the eyes, in this case). This is further supported by the fact that pars planitis is sometimes associated with other autoimmune conditions such as <a href=\"https://rarediseases.info.nih.gov/gard/10255/multiple-sclerosis/resources/1\" target=\"_blank\">multiple sclerosis</a> and <a href=\"https://rarediseases.info.nih.gov/gard/7607/sarcoidosis/resources/1\" target=\"_blank\">sarcoidosis</a>.[9140][9139] <br />\r\n<br />\r\nAlthough most cases occur <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadically</a> in people with no family history of the condition, pars planitis can rarely affect more than one family member. In these cases, there may be a genetic component; however, a disease-causing <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> and specific <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/inheritancepatterns\" target=\"_blank\">inheritance pattern</a> have not been identified.[9142]","dateModified":"2015-06-22T21:15:00","resourceClassificationName":"Cause","references":[{"referenceId":9139,"authors":"","articleTitle":"Pars Planitis","bookWebsiteJournalTitle":"NORD","date":"2008","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/pars-planitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9140,"authors":"Robert H Janigian, Jr, MD","articleTitle":"Intermediate Uveitis","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1208794-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9142,"authors":"","articleTitle":"PARS PLANITIS","bookWebsiteJournalTitle":"OMIM","date":"2001","volume":"","pages":"","url":"http://www.omim.org/entry/606177","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8988,"questionText":"How is pars planitis diagnosed?","answerText":"Pars planitis is typically diagnosed based on a specialized eye examination. During the exam, the <a href=\"http://www.aapos.org/terms/conditions/132\" target=\"_blank\">ophthalmologist</a> will typically see clusters of white blood cells trapped within the eyeball that are called snowballs (or \"inflammatory exudate\"). If these clusters are located on the pars plana, they are known as snowbanks. Snowbanks are considered a \"hallmark\" sign of pars planitis.[9139][9140]<br />\r\n<br />\r\nIt is often recommended that people over age 25 with pars planitis have an <a href=\"http://www.nlm.nih.gov/medlineplus/mriscans.html\" target=\"_blank\">MRI</a> of their brain and spine to rule out <a href=\"https://rarediseases.info.nih.gov/gard/10255/multiple-sclerosis/resources/1\" target=\"_blank\">multiple sclerosis</a>.[9144]","dateModified":"2015-06-23T13:45:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":9139,"authors":"","articleTitle":"Pars Planitis","bookWebsiteJournalTitle":"NORD","date":"2008","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/pars-planitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9140,"authors":"Robert H Janigian, Jr, MD","articleTitle":"Intermediate Uveitis","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1208794-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9144,"authors":"","articleTitle":"Uveitis","bookWebsiteJournalTitle":"MedlinePlus","date":"September 2014","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001005.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6116,"questionText":"How might pars planitis be treated?","answerText":"The first approach to treating pars planitis is&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroid</a> eye drops or injections&nbsp;near the eye to control inflammation.&nbsp;Non-steroidal anti-inflammatory drugs (NSAIDs, including <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682878.html\" target=\"_blank\">aspirin</a>) or steroid&nbsp;medications (such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a>) can&nbsp;be taken by mouth. If these strategies are not successful, other medications may be given to reduce the body's <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000821.htm\" target=\"_blank\">immune response</a> (medications called immunosuppressants, such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a>).[9140][9141]&nbsp; <br />\r\n<br />\r\nIf medications are not effective, surgery may be considered.&nbsp;<a href=\"http://www.radiologyinfo.org/en/info.cfm?pg=cryo\" target=\"_blank\">Cryotherapy</a> has been performed in affected&nbsp;people to remove eye tissue that&nbsp;has inflammation.&nbsp;Although this surgery has been shown to&nbsp;be effective in restoring clarity of vision,&nbsp;there are&nbsp;concerns that it may cause damage to other parts of the eye.&nbsp;Another surgery, known as vitrectomy, can be done to remove cloudy fluid (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/1094.htm\" target=\"_blank\">vitreous humor</a>) from the eye.[5144][9140]","dateModified":"2015-06-23T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":5144,"authors":"Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM","articleTitle":"Pars planitis: epidemiology, treatment, and association with multiple sclerosis","bookWebsiteJournalTitle":"Ocular immunology and inflammation","date":"2001","volume":"9","pages":"93-102","url":"http://www.ncbi.nlm.nih.gov/pubmed/11449325","dateAccessed":"2012-04-03T00:00:00"},{"referenceId":9140,"authors":"Robert H Janigian, Jr, MD","articleTitle":"Intermediate Uveitis","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1208794-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9141,"authors":"Michael Tolentino, MD; Reza Dana, MD, MPH, MSc","articleTitle":"Retinal vasculitis associated with primary ocular disorders","bookWebsiteJournalTitle":"UpToDate","date":"November 2014","volume":"","pages":"","url":"","dateAccessed":"2015-06-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":34630,"abbreviatedInquiry":"Once an individual with pars planitis loses vision, can they get it back?&nbsp; And what are the different surgeries that can treat pars planitis?","caseQuestions":[{"questionId":6115,"questionText":"Can vision be restored after it has been affected by pars planitis?","answerText":"Vision loss and reduced visual acuity associated with pars planitis may occur due to a variety of factors including <a href=\"https://nei.nih.gov/health/pucker/pucker\" target=\"_blank\">epiretinal membrane</a>, <a href=\"http://www.geteyesmart.org/eyesmart/diseases/macular-edema.cfm\" target=\"_blank\">macular edema</a>, clouding of the fluid in the center of the eye, inflammation of blood vessels in the eye (vasculitis), and <a href=\"http://www.nlm.nih.gov/medlineplus/cataract.html\" target=\"_blank\">cataracts</a>. Some studies suggest that it is best to treat inflammation in pars planitis quickly and completely to reduce the chance of complications that may affect vision clarity and that, in some cases, treatment can help to restore vision. Unfortunately, some severely affected people may experience progressive vision loss despite appropriate treatment.[5144][9147]","dateModified":"2015-06-23T00:00:00","references":[{"referenceId":5144,"authors":"Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM","articleTitle":"Pars planitis: epidemiology, treatment, and association with multiple sclerosis","bookWebsiteJournalTitle":"Ocular immunology and inflammation","date":"2001","volume":"9","pages":"93-102","url":"http://www.ncbi.nlm.nih.gov/pubmed/11449325","dateAccessed":"2012-04-03T00:00:00"},{"referenceId":9147,"authors":"Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D.","articleTitle":"Pars planitis: a 20-year study of incidence, clinical features, and outcomes","bookWebsiteJournalTitle":"Am J Ophthalmol","date":"December 2007","volume":"144(6)","pages":"812-817","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6116,"questionText":"How might pars planitis be treated?","answerText":"The first approach to treating pars planitis is&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroid</a> eye drops or injections&nbsp;near the eye to control inflammation.&nbsp;Non-steroidal anti-inflammatory drugs (NSAIDs, including <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682878.html\" target=\"_blank\">aspirin</a>) or steroid&nbsp;medications (such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a>) can&nbsp;be taken by mouth. If these strategies are not successful, other medications may be given to reduce the body's <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000821.htm\" target=\"_blank\">immune response</a> (medications called immunosuppressants, such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a>).[9140][9141]&nbsp; <br />\r\n<br />\r\nIf medications are not effective, surgery may be considered.&nbsp;<a href=\"http://www.radiologyinfo.org/en/info.cfm?pg=cryo\" target=\"_blank\">Cryotherapy</a> has been performed in affected&nbsp;people to remove eye tissue that&nbsp;has inflammation.&nbsp;Although this surgery has been shown to&nbsp;be effective in restoring clarity of vision,&nbsp;there are&nbsp;concerns that it may cause damage to other parts of the eye.&nbsp;Another surgery, known as vitrectomy, can be done to remove cloudy fluid (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/1094.htm\" target=\"_blank\">vitreous humor</a>) from the eye.[5144][9140]","dateModified":"2015-06-23T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":5144,"authors":"Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM","articleTitle":"Pars planitis: epidemiology, treatment, and association with multiple sclerosis","bookWebsiteJournalTitle":"Ocular immunology and inflammation","date":"2001","volume":"9","pages":"93-102","url":"http://www.ncbi.nlm.nih.gov/pubmed/11449325","dateAccessed":"2012-04-03T00:00:00"},{"referenceId":9140,"authors":"Robert H Janigian, Jr, MD","articleTitle":"Intermediate Uveitis","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1208794-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9141,"authors":"Michael Tolentino, MD; Reza Dana, MD, MPH, MSc","articleTitle":"Retinal vasculitis associated with primary ocular disorders","bookWebsiteJournalTitle":"UpToDate","date":"November 2014","volume":"","pages":"","url":"","dateAccessed":"2015-06-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":650,"genericName":"Adalimumab","tradeName":"Humira","tradeLink":"https://www.humira.com/uveitis","manufacturer":"","sponsor":"AbbVie Inc.","indication":"September 2018, adalimumab (Humira) received expanded approval for the treatment of non-infectious intermediate, posterior, and panuveitis to include pediatric patients 2 years of age and older. It was approved for use in adults with non-infectious intermediate, posterior, and panuveitis in June 2016.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/humira","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a603010.html"}],"EncodedName":"Pars_planitis"}